机构:[1]Department of Laboratory Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China 大德路总院检验科大德路总院检验科广东省中医院[2]Institute of Laboratory Medicine, Guangdong Medical University, Dongguan 523808, China [3]General Practice Center, Nanhai Hospital, Southern Medical University, Foshan, Guangdong 528244, China [4]Department of Laboratory Medicine, Bo’ai Hospital of Zhongshan City Affiliated with Southern Medical University, Zhongshan 528403, China
The immune checkpoint molecule B7-H4 is highly expressed in various types of cancer, but little is known about its role in the development of cervical lesions associated with human papilloma virus (HPV). This study aimed to investigate the role of B7-H4 in cervical lesion progression and the relationship between B7-H4 and HPV infection. This was a retrospective study of tissue samples from 30 patients with cervical cancer, 28 with cervical intraepithelial neoplasia (CIN), and 75 with cervical inflammatory lesions. Serum-soluble B7-H4 (sB7-H4) was assessed by ELISA. Tissue B7-H4 expression was measured by RT-PCR and immunochemistry. Expression of B7-H4 in dendritic cells was assessed by flow cytometry. sB7-H4 increased gradually from the patients with cervical inflammation to patients with cervical cancer and decreased after treatment. sB7-H4 had a diagnostic value in cervical intraepithelial neoplasia (CIN (area under the curve (AUC)=0.8929) and cervical cancer (AUC = 0.9545). B7-H4 expression in inflammatory cervical tissue and peripheral blood dendritic cells (DCs) increased gradually from inflammation to cancer (P < 0.001). sB7-H4 was positively associated with B7-H4 expression in cervical tissue and DCs and with the frequency of CD4(+)CD25(+)Foxp3(+) regulatory T cells (P < 0.001). The level of sB7-H4, and tissue and DC B7-H4 expression were associated with HPV infection (P < 0.001). These data strongly support the use of sB7-H4 for monitoring the progression of cervical cancer associated with HPV, and for evaluating the immune status of the patients.
基金:
Science and Technology Planning Project of Guangdong Province [2014A020212681]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China [81572088, 81570009, 81273237]; Medical and Health Research Foundation of Foshan city [20190282]; Natural Science Foundation of Guangdong ProvinceNational Natural Science Foundation of Guangdong Province [2015A030313513]
第一作者机构:[1]Department of Laboratory Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China [3]General Practice Center, Nanhai Hospital, Southern Medical University, Foshan, Guangdong 528244, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Qiu Feng,Yuan Chunlei,Xu Jianhua,et al.Role of B7-H4 in the Progression and Prognosis of Cervical Inflammation to Cancer After Human Papilloma Virus Infection[J].JOURNAL OF BIOMEDICAL NANOTECHNOLOGY.2019,15(5):1043-1051.doi:10.1166/jbn.2019.2741.
APA:
Qiu, Feng,Yuan, Chunlei,Xu, Jianhua,Zhang, Junai,Chen, Fu...&Xu, Junfa.(2019).Role of B7-H4 in the Progression and Prognosis of Cervical Inflammation to Cancer After Human Papilloma Virus Infection.JOURNAL OF BIOMEDICAL NANOTECHNOLOGY,15,(5)
MLA:
Qiu, Feng,et al."Role of B7-H4 in the Progression and Prognosis of Cervical Inflammation to Cancer After Human Papilloma Virus Infection".JOURNAL OF BIOMEDICAL NANOTECHNOLOGY 15..5(2019):1043-1051